Chiba Chiba, Japan

Yuka Sato

This inventor holds 1 USPTO granted patent. Top assignees: Chiba University, Nof Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuka Sato. Retrieved from https://idiyas.com/inventor/yuka-sato-or7mouyo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuka Sato: Innovator in Nucleic Acid Delivery Systems

Introduction

Yuka Sato is a prominent inventor based in Chiba, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of cationic lipids for nucleic acid delivery. Her innovative work has the potential to enhance the effectiveness of gene therapy and other medical applications.

Latest Patents

Yuka Sato holds a patent for a cationic lipid having a disulfide bond, which is integral to a lipid membrane structure. This invention includes a nucleic acid introduction agent and a pharmaceutical composition that utilizes the cationic lipid. The patent outlines methods for introducing nucleic acid into cells or target cells and for producing cellular pharmaceuticals. The cationic lipid is designed to serve as an efficient nucleic acid delivery carrier, demonstrating good intracellular dynamics.

Career Highlights

Throughout her career, Yuka Sato has worked with notable organizations, including Nof Corporation and Chiba University. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.

Collaborations

Yuka has collaborated with esteemed colleagues such as Masamichi Tamada and Tokihiro Tanaka. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Yuka Sato's work in the field of nucleic acid delivery systems exemplifies her commitment to advancing biotechnology. Her patented innovations hold promise for future medical applications, making her a noteworthy figure in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…